Cargando…

Cotrimoxazole prophylaxis and antiretroviral therapy: an observational cohort study in China

OBJECTIVE: To assess if cotrimoxazole prophylaxis administered early during antiretroviral therapy (ART) reduces mortality in Chinese adults who are infected with human immunodeficiency virus (HIV). METHODS: We did a retrospective observational cohort study using data from the Chinese national free...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Wei, Wu, Yasong, Wen, Yi, Ma, Ye, Zhao, Decai, Dou, Zhihui, Zhang, Weiwei, Bulterys, Marc, Zhang, Fujie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Health Organization 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371494/ https://www.ncbi.nlm.nih.gov/pubmed/25838611 http://dx.doi.org/10.2471/BLT.14.142745

Ejemplares similares

Linking HIV-Infected TB Patients to Cotrimoxazole Prophylaxis and Antiretroviral Treatment in India
por: Raizada, Neeraj, et al.
Publicado: (2009)

The burden of anemia among Chinese HIV-infected patients following the initiation of antiretroviral therapy in the treat-all era: a nationwide cohort study
por: Wei, Lai, et al.
Publicado: (2023)

Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV
por: Ku, Stephane Wen‐Wei, et al.
Publicado: (2019)

Effects of cotrimoxazole prophylaxis on Talaromyces marneffei infection in HIV/AIDS patients receiving antiretroviral therapy: a retrospective cohort study
por: Jiang, Junjun, et al.
Publicado: (2019)

Changing baseline characteristics among patients in the China National Free Antiretroviral Treatment Program, 2002–09
por: Dou, Zhihui, et al.
Publicado: (2010)

Effect of cotrimoxazole prophylaxis on malaria occurrence in HIV-infected patients on antiretroviral therapy in sub-Saharan Africa*
por: Kasirye, R, et al.
Publicado: (2015)

Attrition among Human Immunodeficiency Virus (HIV)- Infected Patients Initiating Antiretroviral Therapy in China, 2003–2010
por: Zhu, Hao, et al.
Publicado: (2012)

Ten Years of Surveillance for Invasive Streptococcus pneumoniae during the Era of Antiretroviral Scale-Up and Cotrimoxazole Prophylaxis in Malawi
por: Everett, Dean B., et al.
Publicado: (2011)

Immune restoration in HIV-1-infected patients after 12 years of antiretroviral therapy: a real-world observational study
por: Liu, Jiaye, et al.
Publicado: (2020)

Cotrimoxazole Prophylaxis and Tuberculosis Risk among People Living with HIV
por: Hoffmann, Christopher J., et al.
Publicado: (2014)

Cotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority Trial
por: Polyak, Christina S., et al.
Publicado: (2016)

Cotrimoxazole Prophylaxis Specifically Selects for Cotrimoxazole Resistance in Streptococcus mutans and Streptococcus sobrinus with Varied Polymorphisms in the Target Genes folA and folP
por: William, Buwembo, et al.
Publicado: (2012)

Factors Associated with Coverage of Cotrimoxazole Prophylaxis in HIV-Exposed Children in South Africa
por: Moodley, Dhayendre, et al.
Publicado: (2013)

Changing Mortality and Patterns of Death Causes in HIV Infected Patients — China, 2013–2022
por: Zhao, Yan, et al.
Publicado: (2023)

Metronidazole or Cotrimoxazole Therapy Is Associated with a Decrease in Intestinal Bioavailability of Common Antiretroviral Drugs
por: Dossou-Yovo, Flore, et al.
Publicado: (2014)

HIV-Infected Former Plasma Donors in Rural Central China: From Infection to Survival Outcomes, 1985–2008
por: Dou, Zhihui, et al.
Publicado: (2010)

Cotrimoxazole Prophylaxis and Risk of Severe Anemia or Severe Neutropenia in HAART-Exposed, HIV-Uninfected Infants
por: Dryden-Peterson, Scott, et al.
Publicado: (2013)

National policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between Context, Evidence and Links
por: Hutchinson, Eleanor, et al.
Publicado: (2011)

Impact of Anti-Retroviral Treatment and Cotrimoxazole Prophylaxis on Helminth Infections in HIV-Infected Patients in Lambaréné, Gabon
por: Janssen, Saskia, et al.
Publicado: (2015)

Cotrimoxazole Prophylaxis Associated With Reduced Anemia Hazard in HIV-Exposed Infants in a Malaria-Endemic Setting
por: Ewing, Alexander, et al.
Publicado: (2017)

Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis
por: Prendergast, Andrew J., et al.
Publicado: (2016)

Effect of cotrimoxazole prophylaxis on the incidence of malaria in HIV-infected children in 2012, in Abidjan, Côte d’Ivoire: a prospective cohort study
por: Mounkaila Harouna, Aïda, et al.
Publicado: (2015)

Successful treatment of cerebral toxoplasmosis with cotrimoxazole
por: Patil, Harsha V., et al.
Publicado: (2011)

Cotrimoxazole - optimal dosing in the critically ill
por: Brown, Glen R
Publicado: (2014)

The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis
por: Juma, Dennis W., et al.
Publicado: (2019)

Facilitators and barriers to cotrimoxazole and nevirapine prophylaxis among HIV exposed babies: a qualitative study from Harare, Zimbabwe
por: Sibanda, E, et al.
Publicado: (2012)

Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design
por: Anywaine, Zacchaeus, et al.
Publicado: (2015)

Increased malaria parasitaemia among adults living with HIV who have discontinued cotrimoxazole prophylaxis in Kitgum district, Uganda
por: Orishaba, Philip, et al.
Publicado: (2020)

Comparison between Itraconazole and Cotrimoxazole in the Treatment of Paracoccidiodomycosis
por: Cavalcante, Ricardo de Souza, et al.
Publicado: (2014)

Cotrimoxazole: Stevens-Johnson syndrome: case report
Publicado: (2021)

Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled study
por: Kasirye, Ronnie P., et al.
Publicado: (2016)

121 Progress, achievements and challenges: a review of China’s free antiretroviral therapy program
por: Zhang, Fujie
Publicado: (2014)

Manuscript title: Facilitators and barriers to cotrimoxazole prophylaxis among HIV exposed babies: a qualitative study from Harare, Zimbabwe
por: Sibanda, Euphemia L., et al.
Publicado: (2015)

Cotrimoxazole prophylaxis was associated with enteric commensal bacterial resistance among HIV‐exposed infants in a randomized controlled trial, Botswana
por: Powis, Kathleen M, et al.
Publicado: (2017)

Brief Report: Cessation of Long-Term Cotrimoxazole Prophylaxis in HIV-Infected Children Does Not Alter the Carriage of Antimicrobial Resistance Genes
por: Francis, Freddy, et al.
Publicado: (2020)

Does cotrimoxazole prophylaxis in HIV patients increase the drug resistance of pneumococci? A comparative cross-sectional study in southern Ethiopia
por: Seid, Mohammed, et al.
Publicado: (2020)

Nationwide Cohort Study of Antiretroviral Therapy Timing: Treatment Dropout and Virological Failure in China, 2011–2015
por: Zhao, Yan, et al.
Publicado: (2019)

The Effect of Curcumin and Cotrimoxazole in Salmonella Typhimurium Infection In Vivo
por: Rahayu, Siwipeni Irmawanti, et al.
Publicado: (2013)

Randomised controlled trial testing the effect of cotrimoxazole prophylaxis on morbidity and mortality outcomes in breastfed HIV-exposed uninfected infants: study protocol
por: Coutsoudis, Anna, et al.
Publicado: (2016)

Intermittent Preventive Treatment of Malaria in Pregnancy with Mefloquine in HIV-Infected Women Receiving Cotrimoxazole Prophylaxis: A Multicenter Randomized Placebo-Controlled Trial
por: González, Raquel, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mmmip1htk1pmc0dgl1i5imlfgu